Updated:
CURIS INC
CURIS INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001108205, and its reported industry is Biological...
Overview
CURIS INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001108205, and its reported industry is Biological Products, (No Diagnostic Substances). In 10-K filed on 2026-03-24, it reported annual revenue of USD 9,443,000; net income of USD -7,582,000; total assets of USD 19,966,000 for the fiscal period ended 2025-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- CURIS INC
- Classification
- Public company
- Industry (SIC)
- 2836 — Biological Products, (No Diagnostic Substances)
- Headquarters
- Lexington, MA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- Ticker
- Nasdaq: CRIS
- SEC CIK
- 0001108205
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2025USD | $9.4M | -$7.6M | $20.0M | $5.1M | -$27.2M | |
| FY2024USD | $10.9M | -$43.4M | $41.3M | $20.0M | -$39.6M | |
| FY2023USD | $10.0M | -$47.4M | $77.3M | $26.7M | -$38.4M | |
| FY2022USD | $10.2M | -$56.7M | $108.8M | $19.7M | -$54.3M |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 10-Q | 10-Q | ||
| 424B4 | — | 424B4 | |
| S-1 | — | S-1 | |
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| DEF 14A | DEF 14A | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 8-K | 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research CURIS INC in Altss
Track this company’s investors, transactions and relationships in Altss.